Welcome to the Hausch group!
Overview of Structure-based Drug Research:
- Rational Drug Design
- Identification and validation of novel pharmacological concepts
- Synthesis of macro- or polycyclic substances to control the bioactive conformation
- Quantitative understanding of protein-ligand interactions
- Development of FKBP51 inhibitors as novel antidepressants, analgesics or anti-obesity agents
1.8.: Michael Walz joins the lab. Welcome, Michael!
1.7.: Anna Charalampidou joins the lab. Welcome, Anna!
21.6.: The LOEWE consortium TRABITA coordinated by Prof. Hausch receives funding to explore transient binding pockets in proteins drug targets TU Darmstadt Chemie Aktuell and TU Darmstadt Aktuelle Meldungen
21.6.: Prof. Hausch receives funding for GPCR dug discovery in the LOEWE consortium GLUE Uni Marburg News
17.6.: Three new publications on selective FKBP51-Inhibitors developed by the Hausch group TU Darmstadt Chemie Aktuell
27.3.: Anti-infective drug discovery consortium led by Prof. Hausch receives funding by the BMBF TU Darmstadt Chemie Aktuell